Free Access
| Issue |
Med Sci (Paris)
Volume 36, Number 1, Janvier 2020
Nos jeunes pousses ont du talent !
|
|
|---|---|---|
| Page(s) | 83 - 86 | |
| Section | Partenariat médecine/sciences - Écoles doctorales - Masters | |
| DOI | https://doi.org/10.1051/medsci/2019263 | |
| Published online | 04 February 2020 | |
- Schumacher TN Schreiber RD Neoantigens in cancer immunotherapy. Science 2015 ; 348 : 69–74. [Google Scholar]
- Aldous AR Dong JZ Personalized neoantigen vaccines: a new approach to cancer immunotherapy. Bio Med Chem 2018 ; 26 : 2842–2849. [CrossRef] [PubMed] [Google Scholar]
- Cohen CJ Gartner JJ Horovitz-Fried M et al. Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes. J Clin Invest 2015 ; 125 : 3981–3991. [CrossRef] [PubMed] [Google Scholar]
- Neefjes J Jongsma MLM Paul P et al. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Imm 2011 ; 11 : 823–836. [CrossRef] [Google Scholar]
- Gros A Parkhurst MR Tran E et al. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. Nat Med 2016 ; 22 : 433–438. [CrossRef] [PubMed] [Google Scholar]
- Doorduijn EM Sluijter M Querido BJ et al. TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors. J Clin Invest 2016 ; 126 : 784–794. [CrossRef] [PubMed] [Google Scholar]
- Marijt KA Blijleven L Verdegaal EME et al. Identification of non-mutated neoantigens presented by TAP-deficient tumors. J Exp Med 2018 ; 215 : 2325–2337. [CrossRef] [PubMed] [Google Scholar]
- Leone P Shin EC Perosa F et al. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. J Natl Cancer Inst 2013 ; 105 : 1172–1187. [CrossRef] [PubMed] [Google Scholar]
- Ott PA Hu Z Keskin DB et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 2017 ; 547 : 217–221. [Google Scholar]
- Sahin U Derhovanessian E Miller M et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 2017 ; 547 : 222–226. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.